TP53 and leukemia: After treating the patient’s leukemia cells with 6-mercaptopurine, methotrexate, daunorubicin, and cytarabine, P53 protein levels increased in the cells at diagnosis; however, induction of P53 was greatly suppressed in the cells at relapse (Figure 5d).